Return to Listing

1 result(s) for Head and Neck Cancers

PI Name Protocol # Title
Khaled Tolba STUDY00016230 A Double-Blind, Randomized, Two Arm Phase 2 Study of Nivolumab in Combination with Ipilimumab versus Nivolumab in combination with Ipilimumab placebo Squamous Cell Carcinoma of the Head and Neck (SCCHN)

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080